VEDANTA BIOSCIENCES, INC. — Form D/A
VEDANTA BIOSCIENCES, INC. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2024-08-05. The offering totals $118.5M, of which $118.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-08-05
- Form: D/A
- Accession: 0001677878-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $118.5M
- Amount sold: $118.5M
- Investors: 25
- Date of first sale: 2023-03-01
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-480626
Issuer
- Name: VEDANTA BIOSCIENCES, INC.
- CIK: 0001677878
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 19 BLACKSTONE STREET, CAMBRIDGE, MA, 02139
- Phone: 857-706-1427
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Susan Dillon | Director | Cambridge, MA |
| Martin Heidecker | Director | Cambridge, MA |
| Troy Ignelzi | Director | Cambridge, MA |
| Curt LaBelle | Director | Cambridge, MA |
| John LaMattina | Director | Cambridge, MA |
| Bernat Olle | Director | Cambridge, MA |
| Bennett Shapiro | Director | Cambridge, MA |
| Charles Sherwood | Director | Cambridge, MA |
| Neil Tiwari | Director | Cambridge, MA |
| Daniel Couto | Executive Officer | Cambridge, MA |
| Mark Mullikin | Executive Officer | Cambridge, MA |
| Bernat Olle | Executive Officer | Cambridge, MA |
| Jeffrey Silber | Executive Officer | Cambridge, MA |
| Christopher M Viehbacher | Director | Cambridge, MA |
| John L LaMattina | Director | Cambridge, MA |
| Daniel L Couto | Executive Officer | Cambridge, MA |
| Bharatt Chowrira | Director | Cambridge, MA |
| Mark L Mullikin | Executive Officer | Cambridge, MA |
| Bennett M Shapiro | Director | Cambridge, MA |
| Jeffrey L Silber | Executive Officer | Cambridge, MA |
| Susan M Dillon | Director | Cambridge, MA |
| Bharatt M Chowrira | Director | Cambridge, MA |
| Christopher Viehbacher | Director | Cambridge, MA |
Other filings by this issuer (6)
More